JPWO2021188778A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021188778A5
JPWO2021188778A5 JP2022556035A JP2022556035A JPWO2021188778A5 JP WO2021188778 A5 JPWO2021188778 A5 JP WO2021188778A5 JP 2022556035 A JP2022556035 A JP 2022556035A JP 2022556035 A JP2022556035 A JP 2022556035A JP WO2021188778 A5 JPWO2021188778 A5 JP WO2021188778A5
Authority
JP
Japan
Prior art keywords
unsubstituted
substituted
group
acceptable salt
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022556035A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023518411A (ja
JP7817179B2 (ja
JP2023518411A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/022933 external-priority patent/WO2021188778A2/en
Publication of JP2023518411A publication Critical patent/JP2023518411A/ja
Publication of JPWO2021188778A5 publication Critical patent/JPWO2021188778A5/ja
Publication of JP2023518411A5 publication Critical patent/JP2023518411A5/ja
Priority to JP2025188453A priority Critical patent/JP2026021531A/ja
Application granted granted Critical
Publication of JP7817179B2 publication Critical patent/JP7817179B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022556035A 2020-03-18 2021-03-18 神経刺激性ステロイド及びその使用方法 Active JP7817179B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025188453A JP2026021531A (ja) 2020-03-18 2025-11-07 神経刺激性ステロイド及びその使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062991234P 2020-03-18 2020-03-18
US62/991,234 2020-03-18
PCT/US2021/022933 WO2021188778A2 (en) 2020-03-18 2021-03-18 Neuroactive steroids and their methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025188453A Division JP2026021531A (ja) 2020-03-18 2025-11-07 神経刺激性ステロイド及びその使用方法

Publications (4)

Publication Number Publication Date
JP2023518411A JP2023518411A (ja) 2023-05-01
JPWO2021188778A5 true JPWO2021188778A5 (https=) 2024-03-29
JP2023518411A5 JP2023518411A5 (https=) 2024-03-29
JP7817179B2 JP7817179B2 (ja) 2026-02-18

Family

ID=75478218

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022556035A Active JP7817179B2 (ja) 2020-03-18 2021-03-18 神経刺激性ステロイド及びその使用方法
JP2025188453A Pending JP2026021531A (ja) 2020-03-18 2025-11-07 神経刺激性ステロイド及びその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025188453A Pending JP2026021531A (ja) 2020-03-18 2025-11-07 神経刺激性ステロイド及びその使用方法

Country Status (10)

Country Link
US (1) US20240239835A9 (https=)
EP (1) EP4121438A2 (https=)
JP (2) JP7817179B2 (https=)
CN (1) CN115551874A (https=)
AR (1) AR121609A1 (https=)
AU (1) AU2021238346A1 (https=)
CA (1) CA3175324A1 (https=)
IL (1) IL296371A (https=)
TW (1) TW202143976A (https=)
WO (1) WO2021188778A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201606063RA (en) 2012-01-23 2016-09-29 Sage Therapeutics Inc Neuroactive steroid formulations and methods of treating cns disorders
MX2015002252A (es) 2012-08-21 2015-07-21 Sage Therapeutics Inc Metodos para tratar epilepsia o estado de epilepsia.
JP6470258B2 (ja) 2013-04-17 2019-02-13 セージ セラピューティクス, インコーポレイテッド 19−ノルc3,3−ジ置換c21−n−ピラゾリルステロイドおよびその使用方法
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
JOP20200195A1 (ar) 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
WO2016082789A1 (en) 2014-11-27 2016-06-02 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
TWI904593B (zh) 2016-08-23 2025-11-11 美商賽吉醫療公司 結晶19-去甲c3,3-二取代之c21-n-吡唑類固醇
EP3720867A1 (en) 2017-12-08 2020-10-14 Sage Therapeutics, Inc. Deuterated 21 -[4-cyano-pyrazol-1 -yl]-19-nor-pregan-3. alpha-ol-20-one derivatives for treating cns disorders
MA51568A (fr) 2018-01-12 2021-04-21 Sage Therapeutics Inc Composés aza-, oxa et thia-pregnan-20-one-3.alpha.-ol s'utilisant dans le traitement de troubles du système nerveux central
CN113166193B (zh) 2018-10-12 2025-08-19 萨奇治疗股份有限公司 用于治疗cns病症的在位置10处被环状基团取代的神经活性类固醇
KR20250124139A (ko) * 2022-11-21 2025-08-19 세이지 테라퓨틱스, 인크. 음성 nmda-조정 화합물 및 이의 사용 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
AU698834B2 (en) * 1993-05-24 1998-11-12 Purdue Pharma Ltd. Methods and compositions for inducing sleep
FI972202L (fi) * 1994-11-23 1997-07-17 Cocensys Inc Androstaanit ja pregnaanit GABA-reseptoreiden allosteeriseen muunteluun
RU2194712C2 (ru) * 1995-06-06 2002-12-20 Коукенсис, Инк. НЕЙРОАКТИВНЫЕ СТЕРОИДЫ, ФАРМАЦЕВТИЧЕСКИЙ ПРЕПАРАТ, СПОСОБ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ РАЗЛИЧНЫХ НАРУШЕНИЙ, СПОСОБ ИНДУКЦИИ СНА И СПОСОБ ИНДУКЦИИ АНЕСТЕЗИИ С ИХ ИСПОЛЬЗОВАНИЕМ, СПОСОБ МОДУЛИРОВАНИЯ КОМПЛЕКСА РЕЦЕПТОР ГАМКa-ХЛОРИДНЫЙ ИОНОФОР
AU3967297A (en) * 1996-08-01 1998-02-25 Cocensys, Inc. Use of gaba and nmda receptor ligands for the treatment of migraine headache
HRP20230747T1 (hr) * 2011-09-08 2024-01-05 Sage Therapeutics, Inc. Neuroaktivni steroidi, pripravci i njihova uporaba
ME03809B (me) * 2014-10-16 2021-04-20 Sage Therapeutics Inc KOMPOZICIJE I POSTUPCI ZA LEČENJE POREMEĆAJA CNS-a
CN109503694A (zh) * 2018-11-21 2019-03-22 苏州闻天医药科技有限公司 一种新型gabaa受体调节剂及其用途
IL283629B2 (en) 2018-12-05 2026-03-01 Sage Therapeutics Inc Neuroactive steroids and methods of using them
WO2020135454A1 (zh) * 2018-12-26 2020-07-02 张家口华健致远生物科技有限公司 一类类固醇化合物及其用途
CR20240234A (es) 2019-05-31 2024-07-09 Sage Therapeutics Inc ESTEROIDES NEUROACTIVOS Y COMPOSICIONES DE ESTOS (Divisional 2021-629)
CN112391512B (zh) * 2019-08-13 2022-03-18 宝山钢铁股份有限公司 一种高磁感取向硅钢及其制造方法
WO2021142477A1 (en) 2020-01-12 2021-07-15 Brii Biosciences, Inc. Neuroactive steroids and pharmaceutical composition containing the same
JP2024074633A (ja) * 2022-11-21 2024-05-31 小松ウオール工業株式会社 間仕切り装置と、間仕切り装置における横桟の支持構造

Similar Documents

Publication Publication Date Title
JPWO2021188778A5 (https=)
JP6434511B2 (ja) ジヒドロピリミジン誘導体およびその中間体の製造方法
JP2005514398A5 (https=)
RU2016151727A (ru) Нейроактивные стероиды, композиции и их применения
ES2609578T3 (es) Amino-quinolinas como inhibidores de quinasa
JP2016510758A5 (https=)
JP2017531020A5 (https=)
JP2021510695A5 (https=)
JPWO2019213526A5 (https=)
CA2509413A1 (en) Benzazepine derivatives for the treatment of neurological disorders
JP2014508169A5 (https=)
JP2023164918A5 (https=)
JPWO2022051583A5 (https=)
JPWO2021133896A5 (https=)
JPWO2023016529A5 (https=)
RU2016144076A (ru) Сильнодействующие и селективные ингибиторы вируса гепатита с
JPWO2020243488A5 (https=)
JPWO2020264512A5 (https=)
JPWO2020033520A5 (https=)
JPWO2019213470A5 (https=)
ES3030482T3 (en) Anticancer compounds
JPWO2020077255A5 (https=)
JP2023551435A (ja) B型肝炎ウイルス感染症の処置及び予防のためのn置換4-(1,3-アリールオキサゾロ-2-イル)フェニル化合物
JPWO2023122140A5 (https=)
CA2479481A1 (en) Therapeutic ion channel blocking agents and methods of use thereof